Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Thermo Fisher Scientific (NY:TMO)

490.30 -4.51 (-0.91%)
Streaming Delayed Price Updated: 10:21 AM EDT, Aug 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Thermo Fisher Scientific

< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
9 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Morgan Stanley Reveals Top 20 AI-Driven Stocks as Adoption Hits Critical Mass
Katy Huberty, the Global Head of Research at Morgan Stanley, has spotlighted 20 stocks from companies that are likely to see significant benefits from the adoption of Artificial Intelligence (AI). 
Via Benzinga
Topics Artificial Intelligence
Goldman Sachs Predicts Gradual Recovery For Tools And Contract Research Sector In 2025, Stable Large Pharma Spending Key To Recovery
Goldman Sachs predicts a gradual recovery for Life Sciences Tools in 2025, with bioprocessing gaining traction and improved investor sentiment likely. 
Via Benzinga
Thermo Fisher Scientific Unusual Options Activity For January 21
 
Via Benzinga
$100 Invested In Thermo Fisher Scientific 15 Years Ago Would Be Worth This Much Today
 
Via Benzinga
How Is The Market Feeling About Thermo Fisher Scientific?
 
Via Benzinga
Check Out What Whales Are Doing With TMO
 
Via Benzinga
Cash Flow Focus: Thermo Fisher, Energy Transfer, and NetEase
Companies with strong cash flow and a history of impressing Wall Street analysts may make excellent prospects for 2025; TMO, ET, and NTES are three to watch. 
Via MarketBeat
Thermo Fisher Scientific’s Olink Platform Selected for World’s Largest Human Proteome Study
From Thermo Fisher Scientific Inc.
Via Business Wire
Thermo Fisher Scientific to Present at 43rd Annual J.P. Morgan Healthcare Conference on January 14, 2025
From Thermo Fisher Scientific Inc.
Via Business Wire
Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, January 30, 2025
From Thermo Fisher Scientific Inc.
Via Business Wire
Market Whales and Their Recent Bets on TMO Options
 
Via Benzinga
Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 20 Years
 
Via Benzinga
This Omeros Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
 
Via Benzinga
Quest Diagnostics (NYSE: DGX) And Mainz Biomed (NASDAQ: MYNZ) Team Up To Commercialize ColoAlert Early Cancer Detection Screening In The U.S.
Quest Diagnostics (NYSE: DGX) And Mainz Biomed (NASDAQ: MYNZ) Team Up To Commercialize ColoAlert Early Cancer Detection Screening In The U.S. 
Via News Direct
Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 10 Years
 
Via Benzinga
Thermo Fisher Scientific Completes $1B Share Repurchase
From Thermo Fisher Scientific Inc.
Via Business Wire
Mainz Biomed Announces Reverse Stock Split Soon After Collaborating With MedTech Giant Thermo Fisher Scientific
Mainz Biomed partners with Thermo Fisher to develop advanced colorectal cancer screening tools while enhancing ColoAlert for faster, accurate results. 
Via Benzinga
Mainz Biomed Inks Major Deal To Develop A Next-Generation Cancer Test
Mainz Biomed Inks Major Deal To Develop A Next-Generation Cancer Test 
Via News Direct
Thermo Fisher Scientific Authorizes $4 Billion of Share Repurchases
From Thermo Fisher Scientific Inc.
Via Business Wire
The Oncology Bet Is Already Paying Off For Pfizer
With the downfall of Covid-19, pharmaceutical companies turned to oncology in search for their next growth story. Earlier in October, Pfizer Inc (NYSE: PFE) reported its third quarter revenue grew 14%... 
Via Benzinga
Healthcare Giant Thermo Fisher Scientific Inc. (NYSE: TMO) Inks Deal With Mainz Biomed (NASDAQ: MYNZ) To Develop And Commercialize Next Gen Colorectal Cancer Screening
Healthcare Giant Thermo Fisher Scientific Inc. (NYSE: TMO) Inks Deal With Mainz Biomed (NASDAQ: MYNZ) To Develop And Commercialize Next Gen Colorectal Cancer Screening 
Via News Direct
Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets
From Mainz BioMed NV
Via GlobeNewswire
Thermo Fisher Scientific to Present at the Wolfe 2024 Healthcare Conference on November 19, 2024
From Thermo Fisher Scientific Inc.
Via Business Wire
Thermo Fisher Scientific Declares Quarterly Dividend
From Thermo Fisher Scientific Inc.
Via Business Wire
Here's How Much $100 Invested In Thermo Fisher Scientific 15 Years Ago Would Be Worth Today
 
Via Benzinga
Tradepulse Power Inflow Alert: Thermo Fisher Scientific Inc. Climbs Over 9 Points On Session After Alert
 
Via Benzinga
Thermo Fisher Scientific (TMO) Q3 2024 Earnings Call Transcript
TMO earnings call for the period ending September 30, 2024. 
Via The Motley Fool
Topics Earnings
Thermo Fisher Scientific Sails Through Q3 With Mixed Earnings, CEO Says In Great Position To Deliver 2024 Objectives
Thermo Fisher Scientific's Q3 revenue of $10.59 billion missed expectations. Adjusted EPS beat estimates but dropped year-over-year. Guidance for 2024 remains reaffirmed. 
Via Benzinga
Wall Street Slumps For Third Straight Day As Investor Sentiment Fades, Dollar Strength Resumes, Boeing Disappoints: What's Driving Markets Wednesday?
Wall Street is on track for its third consecutive day of losses as investors grow cautious about risky assets, awaiting more clarity on U.S. fiscal and monetary policies and scrutinizing the latest... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.